Adverum Biotechnologies
ADVM
ADVM
126 hedge funds and large institutions have $790M invested in Adverum Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 52 increasing their positions, 30 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
14% more capital invested
Capital invested by funds: $693M → $790M (+$97.1M)
9% more funds holding
Funds holding: 116 → 126 (+10)
0.83% more ownership
Funds ownership: 9.31% → 10.14% (+0.83%)
Holders
126
Holding in Top 10
7
Calls
$12.2M
Puts
$1.14M
Top Buyers
| 1 | +$71.1M | |
| 2 | +$69.1M | |
| 3 | +$18.6M | |
| 4 |
DM
Deerfield Management
New York
|
+$18.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.7M |
Top Sellers
| 1 | -$8.71M | |
| 2 | -$5.08M | |
| 3 | -$3.63M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.32M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.79M |